Abstract | OBJECTIVE: METHODS: The levels of EPO and EPOR in plasma were determined by ELISA kit. mRNA expression levels of EPO and EPOR were determined by RT-RCR. The protein expression levels of EPO and EPOR were detected by Western blot. RESULTS: The EPO protein levels in marrow plasma of ALL and AML group were significantly higher than those in the control group (P<0.05), EPOR protein levels in ALL and AML group were significantly lower than those in the control group (P<0.05). The mRNA levels of EPO and EPOR in ALL and AML groups were significantly higher than those in the control group (P<0.05). The mRNA levels of EPO and EPOR in the high risk ALL and AML groups were significantly higher than those in the medium, low risk group and the control group (P<0.05). The protein expression levels of EPO and EPOR in ALL and AML groups were significantly higher than that in control group (P<0.05). The mRNA levels of EPO and EPOR in ALL and AML groups did not correlate with hemoglobin level and erythrocyte count (P>0.05). CONCLUSION: The expressions of EPO and EPOR is higher in ALL and AML patients. The expression levels of EPO and EPOR relate with the risk of ALL and AML. High risk patients have higher expression levels of EPO and EPOR, however, the expression levels of EPO and EPOR do not correlate with hemoglobin level and erythrocyte counting.
|
Authors | Run-Mei Tian, Cheng-Shuang Huang, Qiong Su, Liang Shi, Xi Luo, Yan Chen |
Journal | Zhongguo shi yan xue ye xue za zhi
(Zhongguo Shi Yan Xue Ye Xue Za Zhi)
Vol. 27
Issue 4
Pg. 1026-1032
(Aug 2019)
ISSN: 1009-2137 [Print] China |
PMID | 31418352
(Publication Type: Journal Article)
|
Chemical References |
- Receptors, Erythropoietin
- Erythropoietin
|
Topics |
- Bone Marrow
- Erythropoietin
- Gene Expression
- Humans
- Leukemia, Myeloid, Acute
- Receptors, Erythropoietin
|